GRI Bio (GRI) vs Propanc Biopharma (PPCB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Propanc Biopharma is the larger company by market cap ($4.6 million vs $3.7 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | GRI | PPCB |
|---|---|---|
| Share price | $1.68 | $0.471 |
| Market cap | $3.67M | $4.63M |
| 1-day change | -9.19% | -5.55% |
| EPS (TTM) | $-14.71 | $-17.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $64.12 | $48.75 |
| 52-week low | $1.36 | $0.46 |
| Distance from 52-week high | -97.38% | -99.03% |
| Average volume | 328.06K | 1.79M |
| Shares outstanding | 2.19M | 9.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GRI vs PPCB FAQ
Which is bigger, GRI Bio or Propanc Biopharma?
Propanc Biopharma (PPCB) is larger, with a market capitalization of $4.63M compared with $3.67M for GRI Bio (GRI).
Are GRI Bio and Propanc Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.